Closing the gap in Heart Failure Monitoring
About Us
Meaningful insight. Wider reach. Sustainable cost.
That’s the monitoring model Audicor is working to build. From hospital to your home.
Heart failure is one of the biggest challenges for clinicians and healthcare systems in the world today. It consumes a disproportionate amount of healthcare budgets, staff time and specialist resources. Mortality reduction remains a challenge particularly as it is difficult to ensure that available treatments are effectively deployed.
How it works!
01
Sensor
The Audicor sensor is a small handled device designed to be held by the patient to their chest for 30 seconds.
This records both electrophysiological and heart sounds information in one simple test.
“The Audicor sensor is an investigational device and is not available for sale
02
Analysis
The signal is passed through a mobile phone app to our cloud based analysis engine. This engine has been developed with large data sets, advanced signal filtering technologies and patented machine learning algorithms to derive a set of Cardiac Acoustic Biomarkers, including EMATc & S3.
03
Real Time Results
The system is being developed so that results can be reviewed by the clinician immediately in the app, viewed as trends and reports in a secure cloud database, and, in future, a programmable notification system designed to flag changes associated with deterioration in heart function for clinical review, potetially allowing early intervention, without adding to clinical review workload.
How Audicor aims to close the gap?
The flexibility of the Audicor Heart Failure Monitoring system, means that it can be used through the care pathway.
Prognostic parameters
EMATc is a non-invasive cardiac acoustic biomarker that has been investigated for its association with cardiac function and prognosis in patients with heart failure.
The ability to measure cardiac acoustic biomarkers quickly and conveniently enables serial comparison of changes in cardiac electromechanical function.
Non-Invasive
The sensor is being designed as a low cost, portable solution that is convenient to use in multiple care settings.
The simple handheld sensor with a rapid test offers a solution that can be deployed at scale without the need for specialist resource and infrastructure to support.
Flexible
The Audicor system is designed to offer a flexible solution that could be used by in hospital clinical staff, as a portable solution for community based heart failure nurses and subsequently by patients themselves in a remote patient monitoring solution to record Cardiac Acoustic Biomarkers for review by clinical teams.
Heart failure has both acute and chronic phases. The flexibility of use offers a comprehensive solution to monitor patients throughout the heart failure care pathway, as appropriate and useful for an individual patients care.
Clinical Evidence
Cardiac acoustic biomarkers have been investigated in published clinical studies, including research into their relationship with cardiac function, prognosis and heart failure management.
These studies provide a scientific foundation for the cardiac acoustic biomarkers and analytical technology incorporated into Audicor’s proposed integrated monitoring system.
Here are a few:
- Authors: Sung S-H, Huang C-J, Cheng H-M, Huang W-M, Yu W-C, Chen C-H
- Source: Journal of Cardiac Failure, 2020.
- Repository: Available via Effect of Acoustic Cardiography-guided Management on 1-year Outcomes in Patients With Acute Heart Failure – Journal of Cardiac Failure
Electromechanical Activation Time in the Prediction of Discharge Outcomes in Patients Hospitalized with Acute Heart Failure Syndrome
- Authors: Chao T, Sung S, Cheng H, Yu W, Wang K, Huang C, Chen C
- Source: Internal Med
- Repository: Available via Electromechanical Activation Time in the Prediction of Discharge Outcomes in Patients Hospitalized with Acute Heart Failure Syndrome
Closing the heart failure monitoring gap. Turning heart sounds and ECG signals into meaningful insights into cardiac function—designed to bring affordable, scalable monitoring to the moments that matter, from hospital discharge to care at home.
Our Team
Graham Prescott
CEO
A proven medtech leader with a passion for turning innovation into clinical and commercial success. With extensive global leadership experience, a track record of building market-leading, profitable businesses and multiple novel medical technologies, successfully commercialised across cardiology, hypertension and trauma, delivering new clinical capabilities and improved patient outcomes.
Career roles at: Hellige, Del Mar Reynolds, Spacelabs, Impact Vitals, Perceptive
Tim Wheeler
CTO
A specialist in advanced medical technologies with deep
expertise in software development, algorithms, data management and cardiac
acoustic technologies. Extensive experience in physiological signal analysis,
clinical applications and complex clinical studies, translating advanced
technology into meaningful clinical insights.
Career roles at: Patient Infosystems, Inovise Medical
Get In Touch!
Email our team or use the form to provide your details and message and we will get back to you as soon as we can.
Audicor Medical is developing a new cardiac acoustic monitoring platform. The proposed integrated system is under development and is not available for commercial sale or routine clinical use. Descriptions of potential clinical applications and benefits are development objectives subject to further validation and applicable regulatory requirements. References to published research or previously cleared technologies do not imply regulatory clearance or established clinical performance of the proposed system. Information on this website is for general informational purposes only and does not constitute medical advice.
© 2026 Audicor Medical Ltd. Registered in England and Wales. Company No. 17354972. Registered office: 3St John’s Innovation Centre, Cowley Road, Milton, Cambridge, CB4 0WS, United Kingdom.